BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Karras SN, Koufakis T, Zebekakis P, Kotsa K. Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun. World J Diabetes 2019; 10(4): 234-240 [PMID: 31040899 DOI: 10.4239/wjd.v10.i4.234]
URL: https://www.wjgnet.com/1948-9358/full/v10/i4/234.htm
Number Citing Articles
1
Aram Minas, Hatef Talebi, Morteza Taravat Ray, Mohammad Yari Eisalou, Marco G. Alves, Mazdak Razi. Insulin treatment to type 1 male diabetic rats protects fertility by avoiding testicular apoptosis and cell cycle arrestGene 2021; 799: 145847 doi: 10.1016/j.gene.2021.145847
2
Mariel Lechner. Adjunctive Therapies for Weight Management in Type 1 DiabetesADCES in Practice 2023; 11(1): 28 doi: 10.1177/2633559X221136868
3
Omolola R. Oyenihi, Marlon E. Cerf, Motlalepula G. Matsabisa, Nicole L. Brooks, Oluwafemi O. Oguntibeju. Effect of kolaviron on islet dynamics in diabetic ratsSaudi Journal of Biological Sciences 2022; 29(1): 324 doi: 10.1016/j.sjbs.2021.08.095
4
Klara R. Klein, Jennifer L.R. Freeman, Imogene Dunn, Chris Dvergsten, M. Sue Kirkman, John B. Buse, Carmen Valcarce, John B. Buse, Klara R. Klein, M. Sue Kirkman, Katherine A. Bergamo, Elizabeth H. Harris, Jean M. Dostou, Laura A. Young, Sriram Machineni, Alex M. Kass, Jamie C. Diner, Milana Dezube, Virginia C. Purrington, Julie M. Uehling, Rachael M. Fraser, Katherine R. Schuch, Jennifer V. Rowell, Ali Qamar, K. Jean Lucas, Luke Snedaker, Stephanie Hoover, Justin Smith, Paul Becton, Jeffrey Hainsworth, Timothy S. Bailey, Juan Pablo Garcia-Naranjo, Niki Nguyen, Bruce W. Bode, Jennifer M. Boyd, Betsy Childs, Pablo Mora, Allison Camacho, Carl D. Vance, Karen Lugo, Anuj Bhargava, Kirstie Stifel, Lisa B. Connery, Birjis Khan, Simone D. Smith, John Parker, Kathryn Zweier, Emily Kronenfeld, Brittany Savoca, Viral N. Shah, Prakriti Joshee, Shivani Dixit, Hal Joseph, Halis Kaan Akturk, Subbulaxami Trikudanathan, Dori Khakpour, Julia Chang, Anne Peters, Pejman Cohan, Mark Harmel, Wendy S . Lane. The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 DiabetesDiabetes Care 2021; 44(4): 960 doi: 10.2337/dc20-2684